REVONDA WILLS: Open Payments
NPI 1932722485 · PRINCETON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$405 in 18 payments from 8 companies in 2025. Trend: 2023 $31 · 2024 $58 · 2025 $405
Food & beverage: $405
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $88 |
| ABBVIE INC. | 4 | $83 |
| Exact Sciences Corporation | 3 | $70 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $69 |
| Novo Nordisk Inc | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $28 |
| Lilly USA, LLC | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: Kerendia, Cologuard Collection Kit, JARDIANCE, VRAYLAR, Ozempic, TRELEGY ELLIPTA, MOUNJARO, QULIPTA.
Industry payments across WV — which companies pay providers there.
